YARROW BIOSCIENCE, INC. Operating Lease, Expense
YARROW BIOSCIENCE, INC. (YARW) reported Operating Lease, Expense of $700.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2020-03-03
- YARROW BIOSCIENCE, INC. operating lease, expense for the quarter ending 2019-12-31 was $200.00K, a 0.00% change year-over-year.
- YARROW BIOSCIENCE, INC. operating lease, expense for the quarter ending 2019-09-30 was $200.00K, a 0.00% change year-over-year.
- YARROW BIOSCIENCE, INC. operating lease, expense for the quarter ending 2019-06-30 was $200.00K, a 0.00% change year-over-year.
- YARROW BIOSCIENCE, INC. operating lease, expense for the quarter ending 2019-03-31 was $200.00K, a 0.00% change year-over-year.
- YARROW BIOSCIENCE, INC. operating lease, expense for fiscal 2019 was $700.00K, a 12.50% decline from fiscal 2018.
- YARROW BIOSCIENCE, INC. operating lease, expense for fiscal 2018 was $800.00K, a 100.00% increase from fiscal 2017.
- YARROW BIOSCIENCE, INC. operating lease, expense for fiscal 2017 was $400.00K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month |
|---|---|---|---|---|
| 2019-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $400.00K derived: sum of 2 quarters · filed 2020-03-03 | $600.00K derived: sum of 3 quarters · filed 2020-03-03 | $700.00K 10-K · filed 2020-03-03 |
| 2019-09-30 | $200.00K 10-Q · filed 2019-10-31 | $400.00K derived: sum of 2 quarters · filed 2019-10-31 | $500.00K 10-Q · filed 2019-10-31 | $800.00K derived: sum of 4 quarters · filed 2020-03-03 |
| 2019-06-30 | $200.00K 10-Q · filed 2019-08-01 | $400.00K 10-Q · filed 2019-08-01 | $600.00K derived: sum of 3 quarters · filed 2020-03-03 | $800.00K derived: sum of 4 quarters · filed 2020-03-03 |
| 2019-03-31 | $200.00K 10-Q · filed 2019-05-02 | $400.00K derived: sum of 2 quarters · filed 2020-03-03 | $600.00K derived: sum of 3 quarters · filed 2020-03-03 | $800.00K derived: sum of 4 quarters · filed 2020-03-03 |
| 2018-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | $400.00K derived: sum of 2 quarters · filed 2020-03-03 | $600.00K derived: sum of 3 quarters · filed 2020-03-03 | $800.00K 10-K · filed 2020-03-03 |
| 2018-09-30 | $200.00K 10-Q · filed 2019-10-31 | $400.00K derived: sum of 2 quarters · filed 2019-10-31 | $600.00K 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $200.00K 10-Q · filed 2019-08-01 | $500.00K 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $200.00K 10-Q · filed 2019-05-02 | |||
| 2017-12-31 | $400.00K 10-K · filed 2020-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |